In episode fifteen of “Selling to Healthcare,” Lisa T. Miller delivers part four of her fluency series with a bold premise — there is a free, publicly available document published every year that tells you exactly which hospitals in your target market are under financial pressure, which executives own those pressure points, and what the cost of inaction is down to the dollar. Most sales teams have never read it. It’s the annual CMS rulemaking cycle, and Lisa argues it contains more actionable intelligence about your hospital accounts than any market research report you’ll ever pay for.
Drawing on years of working directly with hospital leadership teams — from the early CJR model and bundled payments through BPCI and into today’s conversations about TEAM, ACCESS, and rural health — Lisa explains why the real gap in healthcare sales isn’t effort or intelligence, but depth of understanding. The fluent seller reads CMS updates the way a financial analyst reads an earnings release: not for compliance, but to identify where pressure is building, which organizations are most exposed, and what the commercial opportunity looks like before the rest of the market figures it out.
Lisa walks through six CMS programs every healthcare seller needs to understand — HRRP, VBP, TEAM, ACCESS, Rural Health Transformation, and IOTA — breaking down the mechanics, the financial stakes, and the specific commercial openings each one creates. She also reframes a critical mindset shift: CMS isn’t just handing down rules. They’re identifying systemic problems in healthcare delivery and providing funded, structured solutions. The hospitals that recognize this stop treating mandates as compliance exercises and start treating them as funded pathways to performance.
This episode is a practical map for sellers who want to stop showing up with generic value-based care pitch decks and start walking into executive conversations with the specific regulatory fluency that turns the Federal Register into a prospecting calendar.
Highlights of this Episode Include:
The Document Most Sales Teams Never Read: The annual CMS rulemaking cycle is free, public, and contains more actionable account intelligence than any paid market research report — yet most reps ignore it.
HRRP Is Your Easiest Opening: CMS publishes each hospital’s readmission rates and penalty status every year, so you can identify exactly which target accounts are in the penalty tier and which conditions are driving their exposure before you ever make a call.
VBP Speaks the CFO’s Language: The 2% Medicare withhold-and-redistribute model means every executive owns a piece of the score — and sellers who speak in the specific language of the four domains land a categorically different pitch.
TEAM Is Reshaping Surgical Sales Right Now: Mandatory bundled payments make hospitals financially accountable for the full 90-day post-discharge picture, and most competitors aren’t yet speaking the language of episode cost variance, gainsharing, or beneficiary incentives.
ACCESS Is a Board-Level Conversation: A 10-year chronic care model covering two-thirds of the Medicare population isn’t a single sales conversation — it’s a market-shaping event for care management, analytics, and patient engagement companies.
Rural Health Is a $50 Billion Underbuilt Market: Federal investment is reshaping what rural hospitals can afford, and the competitive landscape is far less crowded than urban markets for sellers who actually speak critical access and Rural Emergency Hospital language.
IOTA Turns Transplant Conversations Into Revenue Conversations: Up to $15,000 per case in upside payments means every transplant program leader is paying attention — if you can connect your solution to the specific performance metrics.
Five Questions That Turn CMS Updates Into a Prospecting Calendar: Which hospitals are affected, what’s the exposure, which executive owns it, what does it require them to do differently, and what’s the timeline.
Programs Compound — and So Does Fluency: Improving readmissions lifts VBP, TEAM, and Star Ratings simultaneously. The gap between hospitals avoiding penalties and those building real strategy has never been wider, and neither has the opportunity.
This Week’s Fluency Move: Pull the most recent HRRP penalty data, identify the three accounts in the highest tier, and write one sentence that connects your solution to a specific driving condition in the language of the program. If you can’t write it cleanly, you’ve found the next gap to close.
To learn more about Lisa’s work visit –
Healthcare Sales Masterclass Training
About Lisa T. Miller, MHA
Lisa T. Miller is a healthcare strategist, commercialization advisor, and former CEO of VIE Healthcare Consulting, a firm she founded in 1999 and grew into one of the Top 10 healthcare consulting firms in the United States. In 2022, VIE was acquired by Morgan Stanley Capital Partners.
Over a 30+ year career, Lisa has built a reputation for closing complex, high-value deals with hospital executives and helping organizations improve financial performance, operational efficiency, and patient outcomes. She developed a proven C-Suite selling framework that combines deep industry knowledge, education-based selling, and precise value articulation—enabling companies to access senior decision makers and secure multi-million-dollar engagements.
Lisa’s work is grounded in a rare dual perspective. She has spent decades inside hospitals advising CEOs, CFOs, COOs, and service line leaders on critical operational and financial decisions, while also building and scaling a national consulting firm that competed successfully against much larger organizations. This gives her a clear understanding of how healthcare organizations function—how decisions are made, where initiatives stall, and what drives action at the executive level.
Today, Lisa advises healthcare organizations and companies that sell into healthcare on strategy, growth, and commercialization. Her focus is on helping leaders translate complexity into clear decisions, align solutions with what health systems value, and pursue opportunities that drive measurable impact.
